COVID-19 pandemic has negatively impacted the management of patients with acute and chronic cardiovascular disease: acute coronary syndrome patients were often not timely reperfused, heart failure patients not adequately followed up and titrated, atrial arrhythmias not efficaciously treated and became chronic. New phenotypes of cardiovascular patients were more and more frequent during COVID-19 pandemic and are expected to be even more frequent in the next future in the new world shaped by the pandemic. We therefore aimed to briefly summarize the main changes in the phenotype of cardiovascular patients in the COVID-19 era, focusing on new clinical challenges and possible therapeutic options.
All Keywords
【저자키워드】 cardiovascular disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), Arrhythmias, Acute coronary syndrome, Thrombosis; Heart failure, 【초록키워드】 COVID-19, pandemic, COVID-19 pandemic, arrhythmia, heart failure, management, Patient, phenotype, therapeutic options, treated, changes in, expected, New, impacted, chronic cardiovascular, coronary syndrome, 【제목키워드】 COVID-19, cardiovascular,
【저자키워드】 cardiovascular disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), Arrhythmias, Acute coronary syndrome, Thrombosis; Heart failure, 【초록키워드】 COVID-19, pandemic, COVID-19 pandemic, arrhythmia, heart failure, management, Patient, phenotype, therapeutic options, treated, changes in, expected, New, impacted, chronic cardiovascular, coronary syndrome, 【제목키워드】 COVID-19, cardiovascular,